Impurity Profiling Suite: Decision-support for ICH M7 workflows & regulatory submissions

In this flyer, ACD/Labs demonstrates how the Impurity Profiling Suite™, developed through a collaborative agreement with the US FDA, will help you determine the safety risk of impurities and degradants, and gain insights into the acceptable levels of exposure.